2,alpha-DMT
 | |
 | |
| Systematic (IUPAC) name | |
|---|---|
| 1-(2-methyl-1H-indol-3-yl)propan-2-amine | |
| Clinical data | |
| Identifiers | |
| 4966-28-3 | |
| ChemSpider |
23511903  |
| Chemical data | |
| Formula | C12H16N2 |
|
SMILES
| |
| |
| (what is this?) (verify) | |
2,alpha-DMT, or 2,α-dimethyltryptamine, is a tryptamine and a lesser-known psychedelic drug. It is the 2,a-dimethyl analog of DMT. 2,α-DMT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), Shulgin lists the dosage as 300-500 mg, and the duration as 7-10 hours.[1] 2,α-DMT causes mydriasis and paresthesia. It also produces a calm, drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT.
References
- ↑ Shulgin, Alexander; Ann Shulgin (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press, 422. ISBN 0-9630096-9-9. OCLC 38503252.